Use App for best experience!
Available for Android & iOS
The prothrombin G20210A mutation is the second most common inherited predisposition to hypercoagulability. Heterozygous prothrombin G20210A mutation is associated with a 2 to 6 fold increased lifetime relative risk of VTE. This risk is further increased in combination with pregnancy and OCP use.
Duly filled Genomics Clinical Information Requisition Form is mandatory.